Helius Medical Technologies - HSDT Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HSDT shares.
View HSDT analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued 12-month price objectives for Helius Medical Technologies' stock. Their HSDT share price forecasts range from $5.00 to $5.00. On average, they predict the company's share price to reach $5.00 in the next year. This suggests a possible upside of 1,258.7% from the stock's current price.
View analysts price targets for HSDT or view top-rated stocks among Wall Street analysts.

Helius Medical Technologies' stock was trading at $0.3069 at the start of the year. Since then, HSDT shares have increased by 19.9% and is now trading at $0.3680.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, March 13th 2023.
View our HSDT earnings forecast.

Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its quarterly earnings data on Monday, November, 14th. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.24) by $0.12. The business had revenue of $0.20 million for the quarter, compared to analyst estimates of $0.13 million. Helius Medical Technologies had a negative net margin of 1,741.55% and a negative trailing twelve-month return on equity of 148.27%.

Helius Medical Technologies's stock reverse split on Thursday, December 31st 2020. The 1-35 reverse split was announced on Thursday, December 31st 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 4th 2021. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Helius Medical Technologies issued an update on its fourth quarter 2022 earnings guidance on Monday, January, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $275.00K-$285.00K, compared to the consensus revenue estimate of $280.00K.

Helius Medical Technologies trades on the NASDAQ under the ticker symbol "HSDT."

Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HSDT stock can currently be purchased for approximately $0.37.

Helius Medical Technologies (NASDAQ:HSDT) has a market capitalization of $10.38 million and generates $763,000.00 in revenue each year. The company earns $-18,130,000.00 in net income (profit) each year or ($3.55) on an earnings per share basis.

Helius Medical Technologies' mailing address is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. The official website for the company is heliusmedical.com. The company can be reached via phone at (215) 944-6100 or via email at bbapty@heliusmedical.com.